E. Ohman J or Asset Management AB Buys 209,888 Shares of Surgery Partners, Inc. (NASDAQ:SGRY)

E. Ohman J or Asset Management AB increased its position in shares of Surgery Partners, Inc. (NASDAQ:SGRYFree Report) by 31.0% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 886,088 shares of the company’s stock after purchasing an additional 209,888 shares during the quarter. E. Ohman J or Asset Management AB’s holdings in Surgery Partners were worth $28,567,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also bought and sold shares of the company. DekaBank Deutsche Girozentrale lifted its holdings in shares of Surgery Partners by 102.0% during the 1st quarter. DekaBank Deutsche Girozentrale now owns 2,723 shares of the company’s stock worth $80,000 after acquiring an additional 1,375 shares during the period. Quarry LP raised its position in Surgery Partners by 133.1% during the second quarter. Quarry LP now owns 3,082 shares of the company’s stock valued at $73,000 after purchasing an additional 1,760 shares in the last quarter. EntryPoint Capital LLC lifted its stake in Surgery Partners by 257.1% during the first quarter. EntryPoint Capital LLC now owns 6,399 shares of the company’s stock worth $191,000 after purchasing an additional 4,607 shares during the last quarter. Creative Planning acquired a new stake in shares of Surgery Partners in the 3rd quarter valued at $258,000. Finally, Capstone Investment Advisors LLC increased its stake in shares of Surgery Partners by 38.7% in the 1st quarter. Capstone Investment Advisors LLC now owns 9,151 shares of the company’s stock valued at $273,000 after purchasing an additional 2,551 shares during the last quarter.

Surgery Partners Stock Performance

NASDAQ SGRY opened at $30.87 on Friday. The stock has a fifty day simple moving average of $31.26 and a 200 day simple moving average of $28.05. Surgery Partners, Inc. has a twelve month low of $22.05 and a twelve month high of $36.92. The company has a market capitalization of $3.92 billion, a price-to-earnings ratio of -114.33, a PEG ratio of 2.45 and a beta of 2.75. The company has a quick ratio of 1.69, a current ratio of 1.83 and a debt-to-equity ratio of 0.96.

Surgery Partners (NASDAQ:SGRYGet Free Report) last announced its earnings results on Tuesday, August 6th. The company reported $0.21 EPS for the quarter, beating the consensus estimate of $0.20 by $0.01. Surgery Partners had a positive return on equity of 2.96% and a negative net margin of 1.17%. The business had revenue of $762.10 million for the quarter, compared to analysts’ expectations of $735.94 million. During the same period in the prior year, the business posted $0.25 earnings per share. The firm’s revenue was up 14.2% on a year-over-year basis. Sell-side analysts expect that Surgery Partners, Inc. will post 0.84 EPS for the current year.

Analyst Upgrades and Downgrades

Several brokerages recently weighed in on SGRY. UBS Group assumed coverage on Surgery Partners in a research report on Monday, October 14th. They set a “buy” rating and a $38.00 price objective for the company. Cantor Fitzgerald restated an “overweight” rating and issued a $43.00 price target on shares of Surgery Partners in a research note on Friday, October 4th. Royal Bank of Canada reiterated an “outperform” rating and set a $49.00 price objective on shares of Surgery Partners in a research report on Wednesday, August 7th. Benchmark restated a “buy” rating and issued a $50.00 target price on shares of Surgery Partners in a research report on Monday, August 26th. Finally, Citigroup lowered their price target on shares of Surgery Partners from $38.00 to $36.00 and set a “buy” rating for the company in a report on Wednesday, August 7th. One analyst has rated the stock with a sell rating, two have issued a hold rating and seven have given a buy rating to the stock. Based on data from MarketBeat, Surgery Partners currently has a consensus rating of “Moderate Buy” and a consensus price target of $39.63.

Read Our Latest Report on Surgery Partners

About Surgery Partners

(Free Report)

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.

Featured Articles

Want to see what other hedge funds are holding SGRY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Surgery Partners, Inc. (NASDAQ:SGRYFree Report).

Institutional Ownership by Quarter for Surgery Partners (NASDAQ:SGRY)

Receive News & Ratings for Surgery Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners and related companies with MarketBeat.com's FREE daily email newsletter.